Trial Profile
Recombinant Tetanus Vaccine Phase I/II Clinical Trial
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 11 May 2018
Price :
$35
*
At a glance
- Drugs Recombinant-tetanus-vaccine (Primary) ; Tetanus vaccine
- Indications Tetanus
- Focus Adverse reactions
- 06 May 2018 Status changed from not yet recruiting to recruiting.
- 02 May 2018 New trial record